NICE IDs

21/08/2020

ID1304: Siponimod for treating secondary progressive multiple sclerosis

12/08/2020

ID1591: Belimumab for treating active autoantibody-positive systemic lupus erythematosus

12/08/2020

ID1530: Ravulizumab for treating atypical haemolytic uraemic syndrome (aHUS)

09/07/2020

ID1468: Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor

09/07/2020

ID1586: Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma

09/07/2020

ID1510: Daratumumab in combination for untreated multiple myeloma when stem cell transplant is suitable

08/07/2020

ID1473: Onasemnogene abeparvovec for treating spinal muscular atrophy type 1

08/07/2020

ID1294: Ozanimod for treating relapsing-remitting multiple sclerosis

08/07/2020

ID1534: Apalutamide for treating prostate cancer

08/07/2020

ID1420: Nintedanib for treating interstitial lung disease caused by systemic sclerosis

15/06/2020

ID901: Non-bisphosphonates for treating osteoporosis

10/06/2020

ID3754: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure

04/05/2020

ID1583: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab

28/04/2020

ID945: Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer

23/04/2020

ID1188: Erenumab for preventing migraine

23/04/2020

ID861: Metreleptin for treating lipodystrophy

21/04/2020

ID1368: Fremanezumab for preventing migraine

21/04/2020

ID1596: Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly

21/04/2020

ID1213: Dupilumab for treating severe asthma

21/04/2020

ID968: Zynteglo for treating transfusion-dependent beta-thalassaemia